The evolving field of biodefence: Therapeutic developments and diagnostics

被引：118

作者：

Burnett, JC

Henchal, EA

Schmaljohn, AL

Bavari, S ^{[1
]}

机构：

[1] NCI, Dev Therapeut Program, Based Drug Discovery Grp, SAIC, Frederick, MD 21702 USA

[2] USA, Med Res Inst Infect Dis, Frederick, MD 21702 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2005年 / 4卷 / 04期

关键词：

D O I：

10.1038/nrd1694

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The threat of bioterrorism and the potential use of biological weapons against both military and civilian populations has become a major concern for governments around the world. For example, in 2001 anthrax-tainted letters resulted in several deaths, caused widespread public panic and exerted a heavy economic toll. If such a small-scale act of bioterrorism could have such a huge impact, then the effects of a large-scale attack would be catastrophic. This review covers recent progress in developing therapeutic countermeasures against, and diagnostics for, such agents.

引用

页码：281 / 297

页数：17

共 206 条

[11] Management of anthrax
Bartlett, JG
Inglesby, TV
Borio, L
[J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) : 851 - 858
[12] The Ebola virus VP35 protein functions as a type IIFN antagonist
Basler, CF
Wang, XY
Mühlberger, E
Volchkov, V
Paragas, J
Klenk, HD
Garcia-Sastre, A
Palese, P
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) : 12289 - 12294
[13] Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo
Bausch, DG
Borchert, M
Grein, T
Roth, C
Swanepoel, R
Libande, ML
Talarmin, A
Bertherat, E
Muyembe-Tamfum, JJ
Tugume, B
Colebunders, R
Kondé, KM
Pirard, P
Olinda, LL
Rodier, GR
Campbell, P
Tomori, O
Ksiazek, TG
Rollin, PE
[J]. EMERGING INFECTIOUS DISEASES, 2003, 9 (12) : 1531 - 1537
[14] Lipid raft microdomains: A gateway for compartmentalized trafficking of Ebola and Marburg viruses
Bavari, S
Bosio, CM
Wiegand, E
Ruthel, G
Will, AB
Geisbert, TW
Hevey, M
Schmaljohn, C
Schmaljohn, A
Aman, MJ
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) : 593 - 602
[15] THE ASIALOGLYCOPROTEIN RECEPTOR IS A POTENTIAL LIVER-SPECIFIC RECEPTOR FOR MARBURG VIRUS
BECKER, S
SPIESS, M
KLENK, HD
[J]. JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 393 - 399
[16] Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin
Bell, E
Shamim, M
Whitbeck, JC
Sfyroera, G
Lambris, JD
Isaacs, SN
[J]. VIROLOGY, 2004, 325 (02) : 425 - 431
[17] Intrinsic immunity: a front-line defense against viral attack
Bieniasz, PD
[J]. NATURE IMMUNOLOGY, 2004, 5 (11) : 1109 - 1115
[18] Small tripeptide surrogates with low nanomolar affinity as potent inhibitors of the botulinum neurotoxin B metallo-proteolytic activity
Blommaert, A
Turcaud, S
Anne, C
Roques, BP
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (11) : 3055 - 3062
[19] Hemorrhagic fever viruses as biological weapons - Medical and public health management
Borio, L
Inglesby, T
Peters, CJ
Schmaljohn, AL
Hughes, JM
Jahrling, PB
Ksiazek, T
Johnson, KM
Meyerhoff, A
O'Toole, T
Ascher, MS
Bartlett, J
Breman, JG
Eitzen, EM
Hamburg, M
Hauer, J
Henderson, A
Johnson, RT
Kwik, G
Layton, M
Lillibridge, S
Nabel, GJ
Osterholm, MT
Perl, TM
Russell, P
Tonat, K
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (18): : 2391 - 2405
[20] Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation
Bosio, CM
Aman, MJ
Grogan, C
Hogan, R
Ruthel, G
Negley, D
Mohamadzadeh, M
Bavari, S
Schmaljohn, A
[J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (11) : 1630 - 1638

← 1 2 3 4 5 6 7 8 9 10 →